Skip to content
10-Q

Quarterly Report

MEDRESPONSE CORP.

0001477932-16-013734

← back to feed
Filed
Nov 21, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Nov 21, 2016 9.56M sh
Operating Cash Flow Q3 2016 · Sep 30, 2016 −$571
Operating Cash Flow Q3 2016 · Sep 30, 2015 −$10.5K
Cash And Equivalents Q3 2016 · Sep 30, 2016 $932
Cash And Equivalents Q3 2016 · Dec 31, 2015 $100
Cash And Equivalents Q3 2016 · Dec 31, 2014 $13.63K
Stockholders Equity Q3 2016 · Sep 30, 2016 −$29.69K
Stockholders Equity Q3 2016 · Dec 31, 2015 −$16.97K
Current Liabilities Q3 2016 · Sep 30, 2016 $30.62K
Current Liabilities Q3 2016 · Dec 31, 2015 $17.07K
Total Liabilities Q3 2016 · Sep 30, 2016 $30.62K
Total Liabilities Q3 2016 · Dec 31, 2015 $17.07K
Current Assets Q3 2016 · Sep 30, 2016 $932
Current Assets Q3 2016 · Dec 31, 2015 $100
Total Assets Q3 2016 · Sep 30, 2016 $932
Total Assets Q3 2016 · Dec 31, 2015 $100
Net Income Q3 2016 · Sep 30, 2016 −$3.68K
Net Income Q3 2016 · Sep 30, 2016 −$12.72K
Net Income Q3 2016 · Sep 30, 2015 −$1.87K
Net Income Q3 2016 · Sep 30, 2015 −$10.66K
Operating Income Q3 2016 · Sep 30, 2016 −$3.68K
Operating Income Q3 2016 · Sep 30, 2016 −$12.03K
Operating Income Q3 2016 · Sep 30, 2015 −$1.87K
Operating Income Q3 2016 · Sep 30, 2015 −$10.66K